Rallybio (RLYB) Change in Acquisitions & Divestments (2022 - 2026)
Rallybio (RLYB) posted Change in Acquisitions & Divestments of $17.9 million for Q1 2026, up 62.73% sequentially from $11.0 million in Q4 2025, and down 0.56% YoY from $18.0 million in Q1 2025.
Rallybio (RLYB) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Rallybio has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $17.9 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 0.56% year-over-year to $17.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (down 42.53% YoY) and the FY2025 annual result came in at $46.5 million, down 44.96% from the prior year.
- Change in Acquisitions & Divestments rose to $17.9 million in Q1 2026 per RLYB's latest filing, from $11.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $38.5 million in Q2 2023 and troughed at $7.5 million in Q2 2025.
- A 5-year average of $23.5 million and a median of $22.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 75.15% in 2023, then sank 66.67% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at $34.0 million in 2022, then dropped by 10.56% to $30.4 million in 2023, then tumbled by 48.2% to $15.8 million in 2024, then slumped by 30.16% to $11.0 million in 2025, then soared by 62.73% to $17.9 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $17.9 million, $11.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 17.90 Mn |
| Mar 31, 2026 | 17.90 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 9.97 Mn |
| Sep 30, 2025 | 9.97 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 15.75 Mn |
| Dec 31, 2024 | 15.75 Mn |
| Sep 30, 2024 | 24.42 Mn |
| Sep 30, 2024 | 24.42 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Jun 30, 2024 | 22.50 Mn |
| Mar 31, 2024 | 21.75 Mn |
| Mar 31, 2024 | 21.75 Mn |